Among 87 study participants, 72 were randomly assigned to 4 groups of 18, and 15 were included in the open-label group. Four participants did not receive a booster dose; 67 of 75 study vaccine recipients were followed up at 8 months. An immune response was observed after primary immunization with Ad26.ZEBOV; boosting by MVA-BN-Filo resulted in sustained elevation of specific immunity. Immunization with Ad26.ZEBOV or MVA-BN-Filo did not result in any vaccine-related serious adverse events.
ban bifina o hcm
"Our data showed that, in contrast to MVA-BN-Filo, Ad26.ZEBOV priming generated an initial immune response, and there is evidence for protection from this vaccine given alone in nonhuman primate models. Therefore, this priming dose would be expected to generate at least partial protection against Ebola; for this reason, Ad26.ZEBOV prime schedules with MVA-BN-Filo boost are currently being further evaluated in phase 1, 2, and 3 studies," the authors write.
Scientists at Nanyang Technological University (NTU Singapore) have invented a new way to deliver cancer drugs deep into tumour cells.
The NTU scientists create micro-sized gas bubbles coated with cancer drug particles and iron oxide nanoparticles, and then use magnets to direct these bubbles to gather around a specific tumour.
Ultrasound is then used to vibrate the microbubbles, providing the energy to direct the drug particles into a targeted area.
dia chi ban bifina
This innovative technique was developed by a multidisciplinary team of scientists, led by Asst Prof Xu Chenjie from the School of Chemical and Biomedical Engineering and Assoc Prof Claus-Dieter Ohl from the School of Physical and Mathematical Sciences.
NTU's microbubbles were successfully tested in mice and the study has been published by the Nature Publishing Group in NPG Asia Materials, the top journal for materials sciences in the Asia-Pacific region
bifina o dau ban
ban bifina o hcm
"Our data showed that, in contrast to MVA-BN-Filo, Ad26.ZEBOV priming generated an initial immune response, and there is evidence for protection from this vaccine given alone in nonhuman primate models. Therefore, this priming dose would be expected to generate at least partial protection against Ebola; for this reason, Ad26.ZEBOV prime schedules with MVA-BN-Filo boost are currently being further evaluated in phase 1, 2, and 3 studies," the authors write.
Scientists at Nanyang Technological University (NTU Singapore) have invented a new way to deliver cancer drugs deep into tumour cells.
The NTU scientists create micro-sized gas bubbles coated with cancer drug particles and iron oxide nanoparticles, and then use magnets to direct these bubbles to gather around a specific tumour.
Ultrasound is then used to vibrate the microbubbles, providing the energy to direct the drug particles into a targeted area.
dia chi ban bifina
This innovative technique was developed by a multidisciplinary team of scientists, led by Asst Prof Xu Chenjie from the School of Chemical and Biomedical Engineering and Assoc Prof Claus-Dieter Ohl from the School of Physical and Mathematical Sciences.
NTU's microbubbles were successfully tested in mice and the study has been published by the Nature Publishing Group in NPG Asia Materials, the top journal for materials sciences in the Asia-Pacific region
bifina o dau ban